Travere Therapeutics, Inc.
Total Trades
161
Buys
0
Sells
109
Largest Trade
N/A
Insiders
13
Institutional Funds
215
Inst. Value
$1M+
Activist Filings
50
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Dube Eric M | CHIEF EXECUTIVE OF… | SELL | $1M+ | 60K | $30.10 | Feb 24, 2026 |
| Dube Eric M | CHIEF EXECUTIVE OF… | EXERCISE | $500K+ | 60K | $15.46 | Feb 24, 2026 |
| Inrig Jula | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 2K | $32.21 | Feb 5, 2026 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | SELL | $50K–$100K | 2K | $32.19 | Feb 5, 2026 |
| REED ELIZABETH E | Chief Legal Office… | SELL | $50K–$100K | 3K | $32.18 | Feb 5, 2026 |
| Dube Eric M | CHIEF EXECUTIVE OF… | GRANT | N/A | 114K | — | Feb 4, 2026 |
| Dube Eric M | CHIEF EXECUTIVE OF… | SELL | $1M+ | 100K | $32.28 | Feb 4, 2026 |
| Inrig Jula | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 7K | $32.12 | Feb 4, 2026 |
| Inrig Jula | CHIEF MEDICAL OFFI… | GRANT | N/A | 28K | — | Feb 4, 2026 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 7K | $32.12 | Feb 4, 2026 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | GRANT | N/A | 28K | — | Feb 4, 2026 |
| Heerma Peter | CHIEF COMMERCIAL O… | SELL | $100K–$500K | 7K | $32.12 | Feb 4, 2026 |
| Heerma Peter | CHIEF COMMERCIAL O… | GRANT | N/A | 26K | — | Feb 4, 2026 |
| ROTE WILLIAM E. | Chief Research Off… | GRANT | N/A | 20K | — | Feb 4, 2026 |
| ROTE WILLIAM E. | Chief Research Off… | SELL | $100K–$500K | 12K | $32.87 | Feb 4, 2026 |
| Calvin Sandra | SVP | SELL | $100K–$500K | 4K | $32.12 | Feb 4, 2026 |
| Calvin Sandra | SVP | GRANT | N/A | 15K | — | Feb 4, 2026 |
| REED ELIZABETH E | Chief Legal Office… | GRANT | N/A | 25K | — | Feb 4, 2026 |
| REED ELIZABETH E | Chief Legal Office… | SELL | $100K–$500K | 7K | $32.12 | Feb 4, 2026 |
| Dube Eric M | CHIEF EXECUTIVE OF… | SELL | $1M+ | 60K | $30.09 | Jan 28, 2026 |
| Dube Eric M | CHIEF EXECUTIVE OF… | EXERCISE | $500K+ | 60K | $15.46 | Jan 28, 2026 |
| REED ELIZABETH E | Chief Legal Office… | SELL | $100K–$500K | 10K | $27.34 | Jan 21, 2026 |
| REED ELIZABETH E | Chief Legal Office… | EXERCISE | $100K–$500K | 10K | $19.08 | Jan 21, 2026 |
| Inrig Jula | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 2K | $39.74 | Jan 7, 2026 |
| Heerma Peter | CHIEF COMMERCIAL O… | SELL | $100K–$500K | 5K | $40.00 | Dec 30, 2025 |
| ROTE WILLIAM E. | Chief Research Off… | EXERCISE | $1M+ | 60K | $20.61 | Dec 30, 2025 |
| ROTE WILLIAM E. | Chief Research Off… | SELL | $1M+ | 60K | $40.10 | Dec 30, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFI… | EXERCISE | $100K–$500K | 15K | $8.93 | Dec 30, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFI… | SELL | $500K+ | 15K | $42.00 | Dec 30, 2025 |
| Calvin Sandra | SVP | SELL | $100K–$500K | 7K | $40.00 | Dec 30, 2025 |
| Calvin Sandra | SVP | SELL | $100K–$500K | 3K | $36.00 | Dec 16, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | EXERCISE | $100K–$500K | 20K | $16.23 | Dec 3, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | SELL | $500K+ | 20K | $35.01 | Dec 3, 2025 |
| Calvin Sandra | SVP | SELL | $1M+ | 67K | $36.00 | Nov 6, 2025 |
| Calvin Sandra | SVP | EXERCISE | $1M+ | 61K | $24.02 | Nov 6, 2025 |
| Coughlin Timothy | Director | EXERCISE | $100K–$500K | 18K | $16.95 | Nov 4, 2025 |
| Coughlin Timothy | Director | SELL | $500K+ | 18K | $35.03 | Nov 4, 2025 |
| Heerma Peter | CHIEF COMMERCIAL O… | SELL | $100K–$500K | 6K | $35.00 | Nov 4, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OF… | SELL | $1M+ | 120K | $30.32 | Oct 30, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OF… | EXERCISE | $1M+ | 120K | $15.46 | Oct 30, 2025 |
| Heerma Peter | CHIEF COMMERCIAL O… | SELL | $50K–$100K | 3K | $30.00 | Oct 30, 2025 |
| REED ELIZABETH E | Chief Legal Office… | EXERCISE | $100K–$500K | 10K | $19.08 | Sep 24, 2025 |
| REED ELIZABETH E | Chief Legal Office… | SELL | $100K–$500K | 10K | $25.00 | Sep 24, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | SELL | $1K–$15K | 573 | $18.51 | Sep 5, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | SELL | $1K–$15K | 470 | $17.31 | Aug 28, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 815 | $14.65 | Jul 2, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | EXERCISE | N/A | 5K | — | May 6, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OF… | SELL | $15K–$50K | 2K | $21.05 | May 6, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 19K | $21.05 | May 6, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OF… | EXERCISE | N/A | 19K | — | May 6, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 215 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 5.6M | $1M+ | SH |
| STATE STREET CORP | 4.8M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 4.3M | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 3.8M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $1M+ | SH |
| Stephens Investment Management Group LLC | 1.7M | $1M+ | SH |
| EMERALD ADVISERS, LLC | 1.6M | $1M+ | SH |
| EMERALD MUTUAL FUND ADVISERS TRUST | 948K | $1M+ | SH |
| Hudson Bay Capital Management LP | 900K | $1M+ | SH (Put) |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 868K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 808K | $1M+ | SH |
| Ensign Peak Advisors, Inc | 805K | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 700K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 666K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 623K | $1M+ | SH |
| PANAGORA ASSET MANAGEMENT INC | 587K | $1M+ | SH |
| Fiera Capital Corp | 574K | $1M+ | SH |
| Pictet Asset Management Holding SA | 535K | $1M+ | SH |
| Aberdeen Group plc | 518K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 18, 2026
4.2%
3.8M shares
SC 13G/A · Feb 13, 2026
0.0%
0 shares
SC 13G · Feb 9, 2026
5.3%
4.8M shares
SC 13G · Jan 8, 2026
11.7%
10.6M shares
SC 13G/A · Nov 14, 2025
7.5%
6.7M shares
SC 13G/A · Nov 14, 2025
11.9%
10.6M shares
SC 13G · Oct 14, 2025
5.5%
4.9M shares
SC 13G/A · Aug 7, 2025
12.8%
11.3M shares
SC 13G/A · Jul 29, 2025
6.7%
6.0M shares
SC 13G/A · May 15, 2025
10.0%
8.9M shares
Rock Springs Capital Management LP
SC 13G/A · May 15, 2025
3.3%
2.9M shares
SC 13G/A · May 15, 2025
5.4%
4.8M shares
SC 13G · May 14, 2025
8.5%
7.6M shares
SC 13G/A · Apr 30, 2025
5.7%
5.0M shares
SC 13G/A · Apr 17, 2025
7.5%
6.7M shares
SC 13G/A · Feb 14, 2025
9.6%
7.4M shares
SC 13G/A · Feb 14, 2025
2.4%
2.1M shares
Rock Springs Capital Management LP
SC 13G/A · Feb 14, 2025
5.7%
5.0M shares
SC 13G/A · Feb 7, 2025
4.9%
4.3M shares
SC 13G/A · Feb 5, 2025
9.4%
8.0M shares
SC 13G/A · Jan 31, 2025
7.8%
6.7M shares
SC 13G/A · Nov 14, 2024
10.0%
7.6M shares
SC 13G · Nov 14, 2024
5.7%
4.3M shares
SC 13G/A · Nov 14, 2024
0.7%
532K shares
SC 13G/A · Nov 12, 2024
9.0%
6.9M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G/A · Nov 8, 2024
1.7%
1.3M shares
SC 13G/A · Nov 4, 2024
9.0%
6.9M shares
STATE STREET CORPORATION 04-2456637
SC 13G/A · Oct 18, 2024
3.6%
2.7M shares
Rock Springs Capital Management LP
SC 13G · May 1, 2024
5.8%
4.4M shares
SC 13G/A · Feb 14, 2024
9.8%
7.4M shares
SC 13G/A · Feb 14, 2024
10.0%
7.5M shares
SC 13G/A · Feb 14, 2024
6.3%
4.7M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
7.3%
5.5M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 12, 2024
0.0%
32K shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 25, 2024
7.1%
0 shares
SC 13G/A · Jan 24, 2024
10.6%
8.0M shares
SC 13G/A · Oct 6, 2023
10.3%
7.7M shares
SC 13G/A · May 15, 2023
0.0%
0 shares
SC 13G · Mar 13, 2023
5.9%
4.4M shares
SC 13G/A · Feb 14, 2023
6.2%
4.0M shares
SC 13G/A · Feb 14, 2023
5.5%
3.6M shares
SC 13G/A · Feb 14, 2023
10.0%
6.4M shares
SC 13G/A · Feb 14, 2023
7.1%
4.6M shares
SC 13G/A · Feb 10, 2023
4.9%
3.1M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 10, 2023
7.9%
5.1M shares
SC 13G/A · Feb 3, 2023
8.1%
5.2M shares
SC 13G · Oct 28, 2022
6.1%
3.9M shares
SC 13G · May 16, 2022
5.4%
3.4M shares
SC 13G · Feb 14, 2022
6.7%
4.1M shares
SC 13G/A · Feb 14, 2022
3.0%
1.8M shares